We are live on ! Find out more
Federated Hermes

Federated Hermes Portfolio holdings

AUM $69.6B
1-Year Est. Return 42.52%
This Fund
S&P 500
This Quarter Est. Return
+10.89%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$36.2B
AUM Growth
+$2.03B
Cap. Flow
-$1.03B
Cap. Flow %
-2.85%
Top 10 Hldgs %
14.34%
Holding
2,349
New
214
Increased
749
Reduced
1,086
Closed
196

Sector Composition

Rank Sector Weight
1 Healthcare 22.91%
2 Financials 14.92%
3 Technology 12.39%
4 Consumer Discretionary 8.32%
5 Consumer Staples 8.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OCUL icon
2051
Ocular Therapeutix
OCUL
$2.35B
$1.01K ﹤0.01%
361
-801,375
-100% -$2.65M
SGTX
2052
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
$986 ﹤0.01%
217
-112
-34% -$639
GNE icon
2053
Genie Energy
GNE
$415M
$920 ﹤0.01%
+89
New +$866
ATNX
2054
DELISTED
Athenex, Inc. Common Stock
ATNX
$918 ﹤0.01%
311
-326
-51% -$1.24K
NNI icon
2055
Nelnet
NNI
$4.56B
$908 ﹤0.01%
10
AMTI
2056
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
$891 ﹤0.01%
2,121
+677
+47% +$681
BIRD icon
2057
Smartbird Inc
BIRD
$29.6M
$871 ﹤0.01%
+18
New +$1.05K
AYTU icon
2058
AYTU BioPharma
AYTU
$21.4M
$860 ﹤0.01%
228
-61
-21% -$230
NWG icon
2059
NatWest
NWG
$73.3B
$853 ﹤0.01%
132
-164
-55% -$961
STRL icon
2060
Sterling Infrastructure
STRL
$14.5B
$853 ﹤0.01%
+26
New +$765
LSF icon
2061
Laird Superfood
LSF
$43.9M
$839 ﹤0.01%
999
-150
-13% -$216
OGN icon
2062
Organon & Co
OGN
$3.58B
$838 ﹤0.01%
30
-214
-88% -$5.47K
OTRK
2063
DELISTED
Ontrak
OTRK
$801 ﹤0.01%
24
-24
-50% -$872
APRE icon
2064
Aprea Therapeutics
APRE
$9.75M
$746 ﹤0.01%
113
-60
-35% -$633
VRNS icon
2065
Varonis Systems
VRNS
$5.45B
$742 ﹤0.01%
+31
New +$708
BDN
2066
Brandywine Realty Trust
BDN
$506M
$707 ﹤0.01%
+115
New +$739
FIGS icon
2067
FIGS
FIGS
$2.32B
$680 ﹤0.01%
101
-399,899
-100% -$2.88M
ZIMV
2068
DELISTED
ZimVie
ZIMV
$663 ﹤0.01%
71
-204
-74% -$1.78K
SRTS icon
2069
Sensus Healthcare
SRTS
$51.9M
$660 ﹤0.01%
89
-18
-17% -$162
VRCA icon
2070
Verrica Pharmaceuticals
VRCA
$84.3M
$652 ﹤0.01%
+24
New +$640
PLAB icon
2071
Photronics
PLAB
$1.6B
$640 ﹤0.01%
38
-1,160
-97% -$19.8K
QUMU
2072
DELISTED
Qumu Corp.
QUMU
$617 ﹤0.01%
690
-76
-10% -$57
WYY icon
2073
WidePoint Corp
WYY
$108M
$604 ﹤0.01%
332
+25
+8% +$55
NTB icon
2074
Bank of N.T. Butterfield & Son
NTB
$2.37B
$596 ﹤0.01%
20
-12,295
-100% -$406K
VNCE icon
2075
Vince Holding Corp
VNCE
$99M
$579 ﹤0.01%
74
-77
-51% -$586

Similar funds

Federated Hermes's Q4 2022 Portfolio in Review

As of Q4 2022, Federated Hermes held 2,349 positions worth $36.2B, up 6% from $34.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Federated Hermes's Q4 2022 filing shows 214 new, 749 increased, 1,086 reduced and 196 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 310,000 shares worth $26.2M. The largest sale was Amgen, an estimated $211M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 23% a quarter earlier, followed by Financials and Technology.

  • Federated Hermes's largest Q4 2022 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 310,000 shares worth $26.2M.
  • Federated Hermes added most to LyondellBasell Industries in Q4 2022, an estimated $165M increase.
  • Federated Hermes's biggest Q4 2022 reduction was Amgen, cutting an estimated $211M.
  • Federated Hermes fully exited Akouos Inc in Q4 2022, selling an estimated $27M.
  • Federated Hermes's ten largest holdings make up 14% of its $36.2B portfolio in Q4 2022.
  • Federated Hermes opened 214 new positions and closed 196 in Q4 2022.
  • Federated Hermes's portfolio value rose 6% quarter-over-quarter to $36.2B.

Based on Federated Hermes's 13F filing for Q4 2022, filed 13 Feb 2023.